FDA Approved: LITHIUM CARBONATE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for Lithium carbonate from Alembic Pharmaceuticals, authorizing an update to an existing product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE (LITHIUM CARBONATE)